These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19138249)

  • 1. Hydroxychloroquine-induced hyperpigmentation: a case report.
    Melikoglu MA; Melikoglu M; Gurbuz U; Budak BS; Kacar C
    J Clin Pharm Ther; 2008 Dec; 33(6):699-701. PubMed ID: 19138249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycholoroquine-induced hyperpigmentation.
    Mir A; Boyd KP; Meehan SA; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
    Ivo R; Lopes CA; Reis R
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
    [No Abstract]   [Full Text] [Related]  

  • 4. Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases.
    de Andrade BA; Fonseca FP; Pires FR; Mesquita AT; Falci SG; Dos Santos Silva AR; Vargas PA; Jorge J; de Almeida OP
    J Cutan Pathol; 2013 Sep; 40(9):833-8. PubMed ID: 23782298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine.
    Sibilia J; Cribier B; Javier RM; Pflumio F; Kuntz JL
    Rev Rhum Engl Ed; 1995 Dec; 62(11):795-7. PubMed ID: 8869222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation.
    Morrison LK; Nordlund JJ; Heffernan MP
    Dermatol Online J; 2009 Dec; 15(12):15. PubMed ID: 20040265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S; Deveci H
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis.
    Callaly EL; FitzGerald O; Rogers S
    Clin Exp Dermatol; 2008 Aug; 33(5):572-4. PubMed ID: 18477009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine.
    Kalampalikis A; Goetze S; Elsner P
    J Dtsch Dermatol Ges; 2012 Dec; 10(12):921-2. PubMed ID: 23190463
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation.
    True DG; Bryant LR; Harris MD; Bernert RA
    Arthritis Rheum; 2002 Jun; 46(6):1698. PubMed ID: 12115210
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
    Lau JF; Dean SM; Rooke TW; Olin JW
    Vasc Med; 2016 Dec; 21(6):558-559. PubMed ID: 27197682
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
    Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
    Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine.
    Lakhanpal S; Duffy J; Griffing WL; Conn DL; Luthra HS
    J Rheumatol; 1985 Oct; 12(5):1028-9. PubMed ID: 4087260
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ; Vermeer MH; Huizinga TW
    Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombopenia secondary to hydroxychloroquine].
    Caminal Montero L; González Marroquín A; Ferro Mosquera J; Susano R
    An Med Interna; 1994 Jun; 11(6):310. PubMed ID: 7918951
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine-induced hyperpigmentation.
    Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ
    J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
    Amichai B; Gat A; Grunwald MH
    J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimalarial drugs for rheumatoid disease during pregnancy.
    Koren G
    Can Fam Physician; 1999 Dec; 45():2869-70. PubMed ID: 10626050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.